Göğüs Hastalıkları

Yazarlar

Merve Ayık Türk
Berna Kömürcüoğlu

Özet

Bu metin, alt solunum yolu enfeksiyonlarından akut bronşit, kronik bronşit, pnömoni ve pnömokok aşılamasını ele almaktadır. Akut bronşit, trakeobronşiyal ağacın yangısal hastalığı olup en sık viral patojenlerden kaynaklanır; genellikle kendi kendini sınırlar ve rutin antibiyotik tedavisi gerektirmez. Kronik bronşit ise en az iki yıl boyunca yılda en az üç ay öksürük ve balgamla seyreden, sigaranın ana risk faktörü olduğu tablodur; temel hedef irritan maruziyetini sonlandırmaktır. Pnömoni, akciğer parankiminin enfeksiyonu ve inflamasyonudur; nefes darlığı, öksürük, ateş ve pas rengi balgam gibi semptomlarla ortaya çıkar. Tanıda fizik muayene ve radyolojik infiltrasyonlar belirleyicidir. Hastaneye yatış kararında CURB-65, PSI, SMART-COP ve A-DROP gibi skorlamalar kullanılır; CURB-65'te 2 ve üzeri puan yatış endikasyonudur. Yoğun bakım yatışında invaziv mekanik ventilasyon ve septik şok majör kriterlerdir. Pnömonide erken antibiyotik başlanması prognoz açısından kritik önem taşır. Korunmada ise 65 yaş üzeri ve kronik hastalığı olan risk gruplarına konjüge (PCV13) ve polisakkarit (PPSV23) pnömokok aşıları önerilmektedir.

Referanslar

Wenzel RP, Fowler AA III. Clinical practice. Acute bronchitis. N Eng J Med 2006;355:2125.

Wark P. Bronchitis (Acute). BMJ Clin Evid. 2015; 2015: 1508.

Clark TW, Medina MJ, Batham S, et al. Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect. 2014;69(5):507–515.

Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):95S–103S.

Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community acquired pneumonia. Arch Intern Med 1997;157:1453.

Smucny JJ, Becker LA, Glazier RH, et al. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract. 1998;47(6):453–460.

Evans AT, Husain S, Durairaj L, et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet. 2002;359(9318):1648–1654.

Pelkonen M, Notkola IL, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006;130:1129–1137. .

Kim V, Han MK, Vance GB, D, et al. The COP-DGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study. Chest 2011;140:626–633. .

American Lung Association. Trends in COPD (chronic bronchitis and emphysema): morbidity and mortality. Washington, DC: Research and Program Services Division, Epidemiology and Statistics Unit, Americal Lung Association; 2011.

Sherman CB, Xu X, Speizer FE, et al. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992;146:855–859.

Swan GE, Hodgkin JE, Roby T, et al. Reversibility of airways injury over a 12-month period following smoking cessation. Chest 1992;101:607–612.

Trotter CL, Stuart JM, George R, et al. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008; 14: 727–733.

Heron M. Deaths: leading causes for 2015. Natl Vital Stat Rep 2017;66(5):1–76.

Almirall J, Serra-Prat M, Bolíbar I, et al. Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies.Respiration. 2017;94(3):299-311.

Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019:e45-e67.

Marti C, Garin N, Grosgurin O, et al. Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.Crit Care. 2012;16(4): R141.

Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44.

Kobayashi M, Bennett NM, Gierke R, et al. Centers for Disease Control and Prevention. MMWR. Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). September 4, 2015;64:944-47.

Yayınlanan

5 Ocak 2022

Lisans

Lisans